메뉴 건너뛰기
The Lancet Neurology
Volumn 7, Issue 1, 2008, Pages 14-16
Neuro-oncology: new insights and advances in treatment
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; IRINOTECAN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;
EID: 37049003471     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70305-8     Document Type: Note
Times cited : (3)
References (7)
  • 1
    • 34250189213 scopus 로고    scopus 로고
    • Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
    • Pelloski C., Ballman K., Furth A., et al. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol 25 (2007) 2288-2294
    • (2007) J Clin Oncol , vol.25 , pp. 2288-2294
    • Pelloski, C.1    Ballman, K.2    Furth, A.3
  • 2
    • 34548213721 scopus 로고    scopus 로고
    • Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
    • Wick A., Felsberg J., Steinbach J., et al. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. J Clin Oncol 25 (2007) 3357-3361
    • (2007) J Clin Oncol , vol.25 , pp. 3357-3361
    • Wick, A.1    Felsberg, J.2    Steinbach, J.3
  • 3
    • 33947191055 scopus 로고    scopus 로고
    • Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
    • Vredenburgh J., Desjardins A., Herndon II J., et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13 (2007) 1253-1259
    • (2007) Clin Cancer Res , vol.13 , pp. 1253-1259
    • Vredenburgh, J.1    Desjardins, A.2    Herndon II, J.3
  • 4
    • 36049037819 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
    • Vredenburgh J., Desjardins A., Herndon II J., et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25 (2007) 4722-4729
    • (2007) J Clin Oncol , vol.25 , pp. 4722-4729
    • Vredenburgh, J.1    Desjardins, A.2    Herndon II, J.3
  • 5
    • 34247100159 scopus 로고    scopus 로고
    • Radiotherapy for glioblastoma in the elderly
    • Keime-Guibert F., Chinot O., Taillandier L., et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 356 (2007) 1527-1535
    • (2007) N Engl J Med , vol.356 , pp. 1527-1535
    • Keime-Guibert, F.1    Chinot, O.2    Taillandier, L.3
  • 6
    • 34249100230 scopus 로고    scopus 로고
    • Chemotherapy for low-grade gliomas: emerging consensus on its benefits
    • Wen P., and DeAngelis L. Chemotherapy for low-grade gliomas: emerging consensus on its benefits. Neurology 68 (2007) 1762-1763
    • (2007) Neurology , vol.68 , pp. 1762-1763
    • Wen, P.1    DeAngelis, L.2
  • 7
    • 34249013376 scopus 로고    scopus 로고
    • Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome
    • Kaloshi G., Benouaich-Amiel A., Diakite F., et al. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68 (2007) 1831-1836
    • (2007) Neurology , vol.68 , pp. 1831-1836
    • Kaloshi, G.1    Benouaich-Amiel, A.2    Diakite, F.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.